HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PD 180970

inhibits p210(Bcr-Abl) tyrosine kinase; structure in first source
Also Known As:
PD-180970; PD180970
Networked: 4 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Jove, Richard: 2 articles (07/2003 - 10/2002)
2. Haura, Eric B: 1 article (07/2003)
3. Turkson, James: 1 article (07/2003)
4. Song, Lanxi: 1 article (07/2003)
5. Karras, James G: 1 article (07/2003)
6. Corbin, Amie S: 1 article (12/2002)
7. Stoffregen, Eric P: 1 article (12/2002)
8. Deininger, Michael W: 1 article (12/2002)
9. La Rosée, Paul: 1 article (12/2002)
10. Druker, Brian J: 1 article (12/2002)

Related Diseases

1. Leukemia
2. BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
3. Lung Neoplasms (Lung Cancer)
4. Blast Crisis (Blast Phase)

Related Drugs and Biologics

1. 17-(allylamino)-17-demethoxygeldanamycin (17AAG)
2. Phosphotransferases (Kinase)
3. imatinib (Gleevec)
4. Protein-Tyrosine Kinases (Tyrosine Kinase)
5. SU 6656